117 related articles for article (PubMed ID: 38043270)
1. An anti-PD-1 antisense oligonucleotide promotes the expression of soluble PD-1 by blocking the interaction between SRSF3 and an exonic splicing enhancer of PD-1 exon 3.
Wang X; Yan L; Guo J; Jia R
Int Immunopharmacol; 2024 Jan; 126():111280. PubMed ID: 38043270
[TBL] [Abstract][Full Text] [Related]
2. Surface PD-1 expression in T cells is suppressed by HNRNPK through an exonic splicing silencer on exon 3.
Wang J; Yan L; Wang X; Jia R; Guo J
Inflamm Res; 2024 May; ():. PubMed ID: 38698180
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of SRSF3 by antisense oligonucleotides sensitizes oral squamous cell carcinoma and breast cancer cells to paclitaxel treatment.
Sun Y; Yan L; Guo J; Shao J; Jia R
Cancer Chemother Pharmacol; 2019 Nov; 84(5):1133-1143. PubMed ID: 31515668
[TBL] [Abstract][Full Text] [Related]
4. Inclusion of hnRNP L Alternative Exon 7 Is Associated with Good Prognosis and Inhibited by Oncogene SRSF3 in Head and Neck Squamous Cell Carcinoma.
Xu L; Shen J; Jia J; Jia R
Biomed Res Int; 2019; 2019():9612425. PubMed ID: 31828152
[TBL] [Abstract][Full Text] [Related]
5. Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion.
Wahid M; Pratoomthai B; Egbuniwe IU; Evans HR; Babaei-Jadidi R; Amartey JO; Erdelyi V; Yacqub-Usman K; Jackson AM; Morris JC; Patel PM; Bates DO
Cancer Immunol Immunother; 2023 Dec; 72(12):4001-4014. PubMed ID: 37973660
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the expression of oncogene SRSF3 by blocking an exonic splicing suppressor with antisense oligonucleotides.
Guo J; Che X; Wang X; Jia R
RSC Adv; 2018 Feb; 8(13):7159-7163. PubMed ID: 35540349
[TBL] [Abstract][Full Text] [Related]
7. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
[TBL] [Abstract][Full Text] [Related]
8. PD-L1 Exon 3 Is a Hidden Switch of Its Expression and Function in Oral Cancer Cells.
Yan L; Sun Y; Guo J; Jia R
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175900
[TBL] [Abstract][Full Text] [Related]
9. Exon 9 skipping of apoptotic caspase-2 pre-mRNA is promoted by SRSF3 through interaction with exon 8.
Jang HN; Lee M; Loh TJ; Choi SW; Oh HK; Moon H; Cho S; Hong SE; Kim DH; Sheng Z; Green MR; Park D; Zheng X; Shen H
Biochim Biophys Acta; 2014 Jan; 1839(1):25-32. PubMed ID: 24321384
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation.
Jia R; Ajiro M; Yu L; McCoy P; Zheng ZM
RNA; 2019 May; 25(5):630-644. PubMed ID: 30796096
[TBL] [Abstract][Full Text] [Related]
11. Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth.
Dewaele M; Tabaglio T; Willekens K; Bezzi M; Teo SX; Low DH; Koh CM; Rambow F; Fiers M; Rogiers A; Radaelli E; Al-Haddawi M; Tan SY; Hermans E; Amant F; Yan H; Lakshmanan M; Koumar RC; Lim ST; Derheimer FA; Campbell RM; Bonday Z; Tergaonkar V; Shackleton M; Blattner C; Marine JC; Guccione E
J Clin Invest; 2016 Jan; 126(1):68-84. PubMed ID: 26595814
[TBL] [Abstract][Full Text] [Related]
12. Modulation of
Sun J; Bai J; Jiang T; Gao Y; Hua Y
RNA Biol; 2019 Dec; 16(12):1794-1805. PubMed ID: 31441370
[TBL] [Abstract][Full Text] [Related]
13. SRSF3-Mediated Ki67 Exon 7-Inclusion Promotes Head and Neck Squamous Cell Carcinoma Progression via Repressing AKR1C2.
Liu M; Lin C; Huang Q; Jia J; Guo J; Jia R
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835286
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the regulatory effects of synthesized antisense oligonucleotides on androgen receptor (AR) exon 3 splicing in prostate cancer cells.
Wang L; Gong S; Zhang X; Azhar Z; Chen J
Gene; 2023 May; 866():147330. PubMed ID: 36871670
[TBL] [Abstract][Full Text] [Related]
15. An exonic splicing enhancer offsets the atypical GU-rich 3' splice site of human apolipoprotein A-II exon 3.
Arrisi-Mercado P; Romano M; Muro AF; Baralle FE
J Biol Chem; 2004 Sep; 279(38):39331-9. PubMed ID: 15247216
[TBL] [Abstract][Full Text] [Related]
16. PTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells.
Guo J; Jia J; Jia R
Sci Rep; 2015 Sep; 5():14548. PubMed ID: 26416554
[TBL] [Abstract][Full Text] [Related]
17. Serine/Arginine-Rich Splicing Factor 3 Modulates the Alternative Splicing of Cytoplasmic Polyadenylation Element Binding Protein 2.
DeLigio JT; Stevens SC; Nazario-Muñoz GS; MacKnight HP; Doe KK; Chalfant CE; Park MA
Mol Cancer Res; 2019 Sep; 17(9):1920-1930. PubMed ID: 31138601
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.
Tang Y; Horikawa I; Ajiro M; Robles AI; Fujita K; Mondal AM; Stauffer JK; Zheng ZM; Harris CC
Oncogene; 2013 May; 32(22):2792-8. PubMed ID: 22777358
[TBL] [Abstract][Full Text] [Related]
19. Antisense oligonucleotide-induced alternative splicing of the APOB mRNA generates a novel isoform of APOB.
Khoo B; Roca X; Chew SL; Krainer AR
BMC Mol Biol; 2007 Jan; 8():3. PubMed ID: 17233885
[TBL] [Abstract][Full Text] [Related]
20. Manipulation of PK-M mutually exclusive alternative splicing by antisense oligonucleotides.
Wang Z; Jeon HY; Rigo F; Bennett CF; Krainer AR
Open Biol; 2012 Oct; 2(10):120133. PubMed ID: 23155487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
